R. Sarkar

发表

Partial correction of murine hemophilia A with neo-antigenic murine factor VIII.

H. Kazazian, R. Sarkar, G. Gao, 2000, Human gene therapy.

Long-term efficacy of adeno-associated virus serotypes 8 and 9 in hemophilia a dogs and mice.

H. Kazazian, R. Sarkar, M. Mucci, 2006, Human gene therapy.

Amelioration of clinical severity through raised fetal hemoglobin in sickle cell anaemia

R. Sarkar, S. Ponnazhagan, 1992, Indian journal of pediatrics.

Role of bone marrow cell transplantation for correcting hemophilia A in mice Running Title : Hemophilia A and bone marrow transplantation

R. Sarkar, Sanjeev Gupta, A. Follenzi, 2012 .

Role of bone marrow transplantation for correcting hemophilia A in mice.

R. Sarkar, Sanjeev Gupta, A. Follenzi, 2012, Blood.

Further characterization of factor VIII-deficient mice created by gene targeting: RNA and protein studies.

H. Kazazian, T. Naas, V. Bedian, 1996, Blood.

Enhanced factor VIII heavy chain for gene therapy of hemophilia A.

X. Yang, R. Sarkar, Jinhui Wang, 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

The enhancing effects of the light chain on heavy chain secretion in split delivery of factor VIII gene.

R. Sarkar, Juan Li, Xiao Xiao, 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

A single adeno‐associated virus (AAV)‐murine factor VIII vector partially corrects the hemophilia A phenotype

H. Kazazian, R. Sarkar, W. Xiao, 2003, Journal of thrombosis and haemostasis : JTH.

Gene transfer to hemophilia A mice via oral delivery of FVIII-chitosan nanoparticles.

K. Leong, R. Sarkar, S. Raut, 2008, Journal of controlled release : official journal of the Controlled Release Society.

Dual vectors expressing murine factor VIII result in sustained correction of hemophilia A mice.

B. Byrne, H. Kazazian, R. Sarkar, 2003, Human gene therapy.

Proteasome inhibitors enhance gene delivery by AAV virus vectors expressing large genomes in hemophilia mouse and dog models: a strategy for broad clinical application.

R. Samulski, T. Kafri, R. Sarkar, 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

Short-term correction of factor VIII deficiency in a murine model of hemophilia A after delivery of adenovirus murine factor VIII in utero.

H. Kazazian, R. Sarkar, G. Lipshutz, 1999, Proceedings of the National Academy of Sciences of the United States of America.

Transplantation of endothelial cells corrects the phenotype in hemophilia A mice

R. Sarkar, S. Gupta, D. Benten, 2005, Journal of thrombosis and haemostasis : JTH.

Lower Inhibitor Development in Hemophilia A Mice following Administration of Recombinant Factor VIII-O-Phospho-L-serine Complex*

H. Kazazian, R. Sarkar, S. Balasubramanian, 2005, Journal of Biological Chemistry.

The molecular basis for cross-reacting material-positive hemophilia A due to missense mutations within the A2-domain of factor VIII.

R. Kaufman, H. Kazazian, R. Sarkar, 1998, Blood.

Hematological status of β-thalassemics in Madras

R. Sarkar, N. Mohan, 1994 .

Long Term Follow Up of Men with Alfuzosin who Voided Successfully Following Acute Urinary Retention*

R. Sarkar, G. Flannigan, T. Shah, 2004, International Urology and Nephrology.

Developmental regulation of human gamma- and beta-globin genes in the absence of the locus control region

S. Weissman, J. Starck, R. Sarkar, 1994 .

Phenotypic correction of a mouse model of hemophilia A using AAV2 vectors encoding the heavy and light chains of FVIII.

H. Kazazian, R. Sarkar, A. Parker, 2003, Blood.

Efficacy and safety of long-term prophylaxis in severe hemophilia A dogs following liver gene therapy using AAV vectors.

H. Kazazian, R. Sarkar, T. Nichols, 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

Absence of a desmopressin response after therapeutic expression of factor VIII in hemophilia A dogs with liver-directed neonatal gene therapy

R. Sarkar, D. Bellinger, T. Nichols, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Naked DNA transfer of Factor VIII induced transgene-specific, species-independent immune response in hemophilia A mice.

H. Ochs, R. Kaufman, D. Rawlings, 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

Correction of the coagulation defect in hemophilia A mice through factor VIII expression in skin.

H. Kazazian, R. Sarkar, S. Fakharzadeh, 2000, Blood.

Total correction of hemophilia A mice with canine FVIII using an AAV 8 serotype.

Lili Wang, H. Kazazian, R. Chandler, 2004, Blood.

The Molecular Basis for Cross-Reacting Material–Positive Hemophilia A Due to Missense Mutations Within the A2-Domain of Factor VIII

R. Kaufman, H. Kazazian, R. Sarkar, 1998 .

Association between the degree of mosaicism and the severity of syndrome in Turner mosaics and Klinefelter mosaics

R. Sarkar, K. Marimuthu, 1983, Clinical genetics.

β‐Thalassaemia mutations and their linkage to β‐haplotypes in Tamil Nadu in Southern India

R. Sarkar, J. Old, R. Venkatesan, 1992 .

The spectrum of β‐thalassaemia mutations on the Indian subcontinent: the basis for prenatal diagnosis

D. Weatherall, R. Sarkar, J. Old, 1991, British journal of haematology.

beta-Thalassaemia mutations and their linkage to beta-haplotypes in Tamil Nadu in southern India.

R. Sarkar, J. Old, R. Venkatesan, 1992, Clinical genetics.

Elevated Gγ:Aγ globin chain ratio in homozygous beta thalassemia

R. Sarkar, S. Ponnazhagan, J. Betsy, 1990 .

Comparison of dexmedetomidine and clonidine for attenuation of sympathoadrenal responses and anesthetic requirements to laryngoscopy and endotracheal intubation

R. Sarkar, Shirsendu Mondal, Hindol Mondal, 2014 .

Complete correction of hemophilia A with adeno-associated viral vectors containing a full-size expression cassette.

R. Sarkar, Jinhui Wang, W. Xiao, 2008, Human gene therapy.

Weissman and Bg Forget the Absence of the Locus Control Region Developmental Regulation of Human Gamma-and Beta-globin Genes In

R. Sarkar, M. Tanaka, A. Scarpa, 2002 .

Hematological status of beta-thalassemics in Madras.

R. Sarkar, N. Mohan, 1994, Indian journal of pediatrics.

Enzymes of the pentose phosphate pathway in glutathione-regulated membrane protection in beta-thalassaemia.

R. Sarkar, S. Ponnazhagan, 1992, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

targeting: RNA and protein studies Further characterization of factor VIII-deficient mice created by gene

T. Naas, V. Bedian, R. Sarkar, 2011 .

Developmental regulation of human gamma- and beta-globin genes in the absence of the locus control region.

J. Starck, R. Sarkar, M. Tanaka, 1994, Blood.

Vectors for a 'double-tagging' assay for protein-protein interactions: localization of the CDK2-binding domain of human p21.

F. Germino, R. Sarkar, Z. X. Wang, 1996, Gene.